Follow
Yazhe Wang
Yazhe Wang
Yale University, University of Nebraska Medical Center
Verified email at yale.edu
Title
Cited by
Cited by
Year
Tumor-penetrating nanoparticles for enhanced anticancer activity of combined photodynamic and hypoxia-activated therapy
Y Wang, Y Xie, J Li, ZH Peng, Y Sheinin, J Zhou, D Oupický
ACS nano 11 (2), 2227-2238, 2017
4252017
Endosomolytic and tumor-penetrating mesoporous silica nanoparticles for siRNA/miRNA combination cancer therapy
Y Wang, Y Xie, KV Kilchrist, J Li, CL Duvall, D Oupický
ACS applied materials & interfaces 12 (4), 4308-4322, 2020
1212020
Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA/siRNA nanotherapy
Y Xie, Y Hang, Y Wang, R Sleightholm, DR Prajapati, J Bader, A Yu, ...
ACS nano 14 (1), 255-271, 2020
1122020
Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis
Y Ding, Y Wang, J Zhou, X Gu, W Wang, C Liu, X Bao, C Wang, Y Li, ...
Biomaterials 35 (25), 7214-7227, 2014
992014
Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy
Y Xie, T Murray-Stewart, Y Wang, F Yu, J Li, LJ Marton, RA Casero Jr, ...
Journal of Controlled Release 246, 110-119, 2017
902017
Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy
Y Ding, Y Wang, Y Opoku-Damoah, C Wang, L Shen, L Yin, J Zhou
Biomaterials 72, 90-103, 2015
522015
Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy
Y Wang, C Wang, Y Ding, J Li, M Li, X Liang, J Zhou, W Wang
Colloids and Surfaces B: Biointerfaces 148, 533-540, 2016
472016
Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness
Y Xie, Y Wang, J Li, Y Hang, L Jaramillo, CJ Wehrkamp, MA Phillippi, ...
Theranostics 8 (16), 4305, 2018
402018
Delivery of miR-200c mimic with poly (amido amine) CXCR4 antagonists for combined inhibition of cholangiocarcinoma cell invasiveness
Y Xie, CJ Wehrkamp, J Li, Y Wang, Y Wang, JL Mott, D Oupický
Molecular pharmaceutics 13 (3), 1073-1080, 2016
322016
Versatile reticular polyethylenimine derivative-mediated targeted drug and gene codelivery for tumor therapy
X Ding, W Wang, Y Wang, X Bao, Y Wang, C Wang, J Chen, F Zhang, ...
Molecular pharmaceutics 11 (10), 3307-3321, 2014
242014
Synthesis and evaluation of chloroquine‐containing DMAEMA copolymers as efficient anti‐miRNA delivery vectors with improved endosomal escape and antimigratory activity in …
Y Xie, F Yu, W Tang, BO Alade, ZH Peng, Y Wang, J Li, D Oupický
Macromolecular bioscience 18 (1), 1700194, 2018
232018
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy
Y Wang, S Malik, HW Suh, Y Xiao, Y Deng, R Fan, A Huttner, RS Bindra, ...
Science Advances 9 (6), eabq7459, 2023
192023
Rerouting native HDL to predetermined receptors for improved tumor-targeted gene silencing therapy
Y Ding, Y Han, R Wang, Y Wang, C Chi, Z Zhao, H Zhang, W Wang, L Yin, ...
ACS applied materials & interfaces 9 (36), 30488-30501, 2017
162017
Promise of chemokine network‐targeted nanoparticles in combination nucleic acid therapies of metastatic cancer
Y Xie, Y Wang, J Li, Y Hang, D Oupický
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 11 (2 …, 2019
122019
Synthesis and biological characterization of clicked chloroquine copolymers as macromolecular inhibitors of cancer cell migration
F Yu, Y Wang, Y Hang, W Tang, Z Zhao, D Oupický
Journal of Polymer Science Part A: Polymer Chemistry 57 (22), 2235-2242, 2019
82019
Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model
ZH Peng, CM Jogdeo, J Li, Y Xie, Y Wang, YM Sheinin, J Kopeček, ...
Pharmaceutics 14 (8), 1725, 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–16